HOVNP news & sentiment — HOVNANIAN ENTERPRISES INC

APR 3·The Globe and MailLow

Hovnanian Shareholders Approve Expanded Stock Incentive Plan

Hovnanian Enterprises' shareholders approved an expanded stock incentive plan at their 2026 Annual Meeting, increasing the pool of shares for future equity awards by 100,000. They also re-elected directors, ratified the independent auditor, and gave advisory approval for executive compensation. Analysts currently rate Hovnanian (HOV) as a Hold with a $113.00 price target, while TipRanks' AI Analyst, Spark, also provides a Neutral assessment.

DEC 27·MarketBeat

Hovnanian Enterprises (NYSE:HOV) Downgraded to Sell Rating by Wall Street Zen

Hovnanian Enterprises (NYSE:HOV) has been downgraded by Wall Street Zen from a "hold" to a "sell" rating, contributing to a consensus "Reduce" rating among analysts. This downgrade follows the company's significant quarterly earnings miss, reporting ($0.51) EPS against a $0.63 consensus, and a 16.5% year-over-year revenue decrease. The stock's performance reflects these concerns, trading below its 50- and 200-day moving averages.

NOV 21·Benzinga

Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday - Azenta ( NASDAQ:AZTA ) , Adaptive Biotechnologies ( NASDAQ:ADPT )

U.S. stocks were mixed, with the Dow Jones gaining around 150 points on Friday. Shares of Ross Stores Inc ( NASDAQ:ROST ) rose sharply during Friday's session after the company reported better-than-expected third-quarter financial results and raised its FY25 GAAP EPS guidance above estimates.

$HOVNP

Hovnanian Shareholders Approve Expanded Stock Incentive Plan

Hovnanian Enterprises (NYSE:HOV) Downgraded to Sell Rating by Wall Street Zen

Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday - Azenta ( NASDAQ:AZTA ) , Adaptive Biotechnologies ( NASDAQ:ADPT )

News on $HOVNP